THE RATE AND CONTROL OF BASE-LINE RED-CELL PRODUCTION IN HEMATOLOGICALLY STABLE PATIENTS WITH UREMIA

Citation
Aj. Erslev et A. Besarab, THE RATE AND CONTROL OF BASE-LINE RED-CELL PRODUCTION IN HEMATOLOGICALLY STABLE PATIENTS WITH UREMIA, The Journal of laboratory and clinical medicine, 126(3), 1995, pp. 283-286
Citations number
13
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
ISSN journal
00222143
Volume
126
Issue
3
Year of publication
1995
Pages
283 - 286
Database
ISI
SICI code
0022-2143(1995)126:3<283:TRACOB>2.0.ZU;2-Z
Abstract
It is generally accepted that the anemia of uremia is caused by decrea sed production of erythropoietin. Nevertheless, the erythropoietin tit ers are not lower than but equal to or higher than in normal non-anemi c individuals, To examine this discrepancy, erythrokinetic studies wer e made of 22 hematologically stable dialysis patients without clinical or laboratory evidence of extrarenal inflammation, infection, or neop lastic disorders. The red cell life span was normal in 14, and because of stable hematocrits, their daily rate of red cell production had to equal their daily rate of red cell destruction, which could be determ ined by dividing the red cell mass by red cell life span. These rates were about one half the rates of normal stable individuals, despite th e same or higher erythropoietin titers. This suggests that the anemia of uremia is caused in part by a decreased bone marrow response to end ogenous erythropoietin.